FDA Approves Remdesivir as First Therapeutic Treatment for Covid — One Week After WHO Concludes Drug Has ‘Little to No Effect’ on Patient Survival

FDA Approves Remdesivir as First Therapeutic Treatment for Covid — One Week After WHO Concludes Drug Has ‘Little to No Effect’ on Patient Survival

Mediaite

Published

FDA approves Remdesivir as first therapeutic treatment for Covid — one week after WHO concludes drug has 'little to no effect' on patient survival

Full Article